In the United States, prostate cancer is the leading cancer among men. Chances of getting prostate cancer increase with age, with 80% of men over 80% having prostate cancer. Currently, around 38,700,000 million men have prostate cancer in North America, Japan and Europe.
This year, more than 180,000 men are expected to be diagnosed with prostate cancer. There are few symptoms in the early stages. You should visit your physician or urologist for prostate cancer screening, which may include a digital rectal exam and a PSA test.
There are no known causes of prostate cancer, but the greatest risk factors are age, family history of the disease and race. The prostate is a walnut sized gland that is between the bladder and rectum. The function of the prostate is to produce semen.
Treatments for prostate cancer include surgery, chemotherapy, brachytherapy, cryotherapy and a new, non-invasive treatment called HIFU. HIFU – High Intensity Focused Ultrasound therapy safely and effectively treats prostate cancer with fewer side effects and a quicker recovery time. The Ultrasound beam directly targets cancer cells in the prostate and effectively destroys them. Research shows the effectiveness of treating localized prostate cancer using HIFU.
The Maple Leaf HIFU clinic is the leading North American clinic for Ablatherm HIFU. They were the first Canadian clinic to offer the procedure and they treat hundreds of patients every year with very positive results. Urological Surgeon and Medical Director, Dr. William Orovan, performs the outpatient procedure in the Cleveland Clinic Canada in downtown Toronto. You can learn more about this new prostate cancer treatment by visiting their website at www.HIFU.ca.
